Tocilizumab monotherapy decreases IL-7/15 and increases MDC (CCL22)/TARC (CCL17) in the serum of patients with microscopic polyangiitis
(The 18th International Vasculitis & ANCA Workshop 2017)
Tocilizumab monotherapy for large vessel vascoulitis. A prospective,single-center,open-labal study
(The 18th International Vasculitis & ANCA Workshop 2017)
Corticosteroid-Free Tocilizumab Monotherapy for Adult Onset Still’s Disease
(Results in Six Month 2016 ACR/ARHP Annual Meeting 2016)
An Increase in Treg- and Th2-Associated Serum Chemokines, MDC (CCL22) and TARC (CCL17) during Tocilizumab Monotherapy in Patients with Microscopic Polyangiitis
(The Annual European Congress of Rheumatology EULAR 2016 2016)
Tocilizumab Mono-Therapy for Polymyalgia Rheumatica ∼ A Single-Center, Open, Single-Arm Trial
(The Annual European Congress of Rheumatology EULAR 2016 2016)
